Abciximab restores the flow through a reoccluded coronary artery after failed thrombolysis and improves clinical status

Author： Blancas R Gómez V Casa R de la Martín F. Moreno JL Oñoro JJ Sobrino N

ISSN： 0956-3075

Source： Clinical Intensive Care, Vol.15, Iss.1, 2004-03, pp. : 7-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Experience with Abciximab During Coronary Revascularisation: An Overview

By Guetta V. Lincoff A.M.

BioDrugs, Vol. 10, Iss. 1, 1998-07 ,pp. : 27-39

Adis International

Access to resources Recommend Favorite

Allopurinol toxicity after coronary artery bypass grafting

By VOETS A J JOESOEF K SHEIK

Clinical Intensive Care, Vol. 9, Iss. 2, 1998-04 ,pp. : 88-89

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Endothelin and acute renal dysfunction after coronary artery bypass grafting

By VOETS A J ZWIENEN J C W VAN J A VAN DER STARRE P

Clinical Intensive Care, Vol. 9, Iss. 4, 1998-08 ,pp. : 153-160

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Atrial fibrillation after coronary artery bypass graft surgery: more than an irritation!

By ARCHBOLD RA CURZEN N

Clinical Intensive Care, Vol. 10, Iss. 4, 1999-08 ,pp. : 109-116

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The Impacts of Cardiac Rehabilitation Program on Exercise Capacity, Quality of Life, and Functional Status of Coronary Artery Disease Patients with Left Ventricular Dysfunction

Rehabilitation Nursing, Vol. 278-4807, Iss. 5, 2015-09 ,pp. : 305-309

John Wiley & Sons Inc

Access to resources Recommend Favorite